Guardant Health, Inc. provided revenue guidance for full year 2023. For the period, the company expects revenue to be in the range of $553 to $556 million, representing growth of 23% to 24% compared to full year 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.51 USD | -4.50% | -12.58% | -16.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.78% | 2.75B | |
-27.70% | 9.87B | |
+27.06% | 2.89B | |
-15.31% | 2.13B | |
-21.41% | 1.65B | |
+68.70% | 1.47B | |
+29.75% | 811M | |
-5.02% | 733M | |
-29.39% | 510M | |
+1.59% | 300M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Provides Revenue Guidance for Full Year 2023